ICD Code K75.81

ICD code K75.81 is used to identify Nonalcoholic Steatohepatitis (NASH), a liver condition characterized by inflammation and damage caused by a buildup of fat in the liver, not related to alcohol consumption. This code is crucial for healthcare providers to accurately document and bill for the diagnosis and treatment of NASH, ensuring proper reimbursement and facilitating effective patient care management.

1. Presence of Fatty Liver: The patient exhibits evidence of hepatic steatosis, either through imaging studies such as ultrasound, CT, or MRI, or through histological examination.

2. Liver Inflammation: Histological examination reveals inflammation in the liver tissue, which is not attributed to alcohol consumption.

3. Ballooning Degeneration of Hepatocytes: The liver biopsy shows ballooning degeneration of hepatocytes, indicating liver cell injury.

4. Absence of Significant Alcohol Consumption: The patient has a history of minimal or no alcohol intake, typically defined as less than 20 grams per day for women and less than 30 grams per day for men.

5. Exclusion of Other Liver Diseases: Other potential causes of liver disease, such as viral hepatitis, autoimmune hepatitis, and drug-induced liver injury, have been ruled out through appropriate testing.

6. Metabolic Syndrome Indicators: The patient may present with features of metabolic syndrome, such as obesity, type 2 diabetes, dyslipidemia, or hypertension, which are commonly associated with NASH.

7. Elevated Liver Enzymes: Blood tests show elevated liver enzymes, particularly alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which suggest liver inflammation or damage.

8. Histological Confirmation: A liver biopsy confirms the diagnosis by showing the characteristic features of NASH, including steatosis, lobular inflammation, and hepatocyte ballooning.

These criteria help healthcare providers accurately diagnose and code for this condition, ensuring appropriate management and billing.

For the ICD code K75.81, which corresponds to Nonalcoholic Steatohepatitis (NASH), the relevant CPT codes that may be applicable for treatment and management include:

1. CPT 99201-99215: These codes cover office or other outpatient visits for the evaluation and management of a patient. The specific code within this range would depend on the complexity and time spent during the visit.

2. CPT 80076: This code is used for a hepatic function panel, which is often ordered to assess liver function and monitor liver conditions such as NASH.

3. CPT 83036: This code is for the Hemoglobin A1c test, which may be relevant for patients with NASH, especially if there is a concern about metabolic syndrome or diabetes.

4. CPT 84460: This code is for alanine aminotransferase (ALT) testing, a liver enzyme test that is commonly used to assess liver health in patients with NASH.

5. CPT 84450: This code is for aspartate aminotransferase (AST) testing, another liver enzyme test that is often performed alongside ALT to evaluate liver function.

6. CPT 76705: This code is for an abdominal ultrasound, which may be used to assess liver size and texture in patients with NASH.

7. CPT 47562: This code is for a laparoscopic cholecystectomy, which might be relevant if gallbladder issues are present alongside NASH.

8. CPT 47000: This code is for a liver biopsy, which may be performed to confirm a diagnosis of NASH and assess the extent of liver damage.

These CPT codes are examples of procedures and tests that might be relevant for the management and treatment of patients with the ICD code K75.81. The selection of specific CPT codes would depend on the individual patient's condition and the healthcare provider's clinical judgment.

Discover how MD Clarity's RevFind software can enhance your revenue cycle management by accurately reading your contracts and detecting underpayments for CPT codes related to ICD code K75.81. Schedule a demo today to see how RevFind can ensure you're receiving the full reimbursement you deserve.